Provention Bio, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2016 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Provention Bio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2016 to Q4 2022.
  • Provention Bio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2022 was -$33.3M, a 28.8% decline year-over-year.
  • Provention Bio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2022 was -$114M, a 0.76% increase year-over-year.
  • Provention Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$114M, a 0.76% increase from 2021.
  • Provention Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$114M, a 16.1% decline from 2020.
  • Provention Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$98.6M, a 128% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 -$114M -$33.3M -$7.45M -28.8% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-29
Q3 2022 -$106M -$28.6M -$1.61M -5.96% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 -$105M -$29.7M -$545K -1.87% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 -$104M -$22M +$10.5M +32.3% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 -$114M -$25.8M +$6.75M +20.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$121M -$27M +$4.28M +13.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$125M -$29.1M -$7.02M -31.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$118M -$32.4M -$19.9M -158% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$98.6M -$32.6M -$22M -209% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-29
Q3 2020 -$76.5M -$31.3M -$21.5M -220% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$55M -$22.1M -$10.1M -84.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$44.9M -$12.6M -$1.61M -14.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$43.3M -$10.5M -$4.86M -85.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 -$38.4M -$9.77M -$4.38M -81.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$34.1M -$12M -$1.67M -16.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$32.4M -$11M -$5.91M -117% Jan 1, 2019 Mar 31, 2019 10-Q 2020-08-06
Q4 2018 -$26.5M -$5.68M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 -$5.39M -$4.03M -296% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$10.3M -$6.3M -156% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-05
Q1 2018 -$5.06M Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-05
Q3 2017 -$1.36M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$4.04M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q4 2016 -$165K Oct 4, 2016 Dec 31, 2016 10-K 2019-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.